Compound Detail
CHEMBL1980391
RG-1530 Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Basic Information
| ChEMBL ID | CHEMBL1980391 |
| Name | RG-1530 |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | UOVCGJXDGOGOCZ-UHFFFAOYSA-N |
86
Targets
103
Activities
2
Assay Types
18
PK Parameters
20
Publications
2
Known Names
1
Indications
7
Mechanisms
Molecular Properties
356.8
MW (Da)
4.75
ALogP
4
HBA
2
HBD
62.3
PSA (Ų)
0.54
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Fibroblast growth factor receptor 1 inhibitor | INHIBITOR | Fibroblast growth factor receptor 1 | ✓ | ✓ |
| Fibroblast growth factor receptor 2 inhibitor | INHIBITOR | Fibroblast growth factor receptor 2 | ✓ | ✓ |
| Tyrosine-protein kinase receptor FLT3 inhibitor | INHIBITOR | Receptor-type tyrosine-protein kinase FLT3 | ✓ | ✓ |
| Platelet-derived growth factor receptor beta inhibitor | INHIBITOR | Platelet-derived growth factor receptor beta | ✓ | ✓ |
| Vascular endothelial growth factor receptor inhibitor | INHIBITOR | Vascular endothelial growth factor receptor | ✓ | ✓ |
| Serine/threonine-protein kinase Aurora-A inhibitor | INHIBITOR | Aurora kinase A | ✓ | ✓ |
| Serine/threonine-protein kinase PLK4 inhibitor | INHIBITOR | Serine/threonine-protein kinase PLK4 | ✓ | ✓ |
Indications
Neoplasms
Activity Summary
Ki 85 meas. best 7.96
IC50 18 meas. best 8.15
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 4820.0 | ng.hr.mL-1 | Macaca mulatta |
| AUC | 86300.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 46700.0 | ng.hr.mL-1 | Mus musculus |
| CL | 7.817 | mL.min-1.kg-1 | Macaca mulatta |
| CL | 8.783 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 8.8 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 1137.92 | nM | Macaca mulatta |
| Cmax | 15022.84 | nM | Rattus norvegicus |
| Cmax | 14210.04 | nM | Mus musculus |
| F | 22.1 | % | Macaca mulatta |
| F | 88.7 | % | Rattus norvegicus |
| F | 96.9 | % | Mus musculus |
| T1/2 | 3.83 | hr | Macaca mulatta |
| T1/2 | 4.7 | hr | Rattus norvegicus |
| T1/2 | 4.32 | hr | Mus musculus |
| Tmax | 4.0 | hr | Macaca mulatta |
| Tmax | 4.0 | hr | Rattus norvegicus |
| Tmax | 2.0 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 24900658 | 10.1021/ml300351e | Mus musculus | 11 |
| 24900658 | 10.1021/ml300351e | Rhesus monkey | 7 |
| 24900658 | 10.1021/ml300351e | Rattus norvegicus | 7 |
| 24900658 | 10.1021/ml300351e | NON-PROTEIN TARGET | 6 |
| 24900658 | 10.1021/ml300351e | MDA-MB-231 | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 24900658 | 10.1021/ml300351e | HUVEC | 3 |
| 24900658 | 10.1021/ml300351e | HCT-116 | 2 |
| 24900658 | 10.1021/ml300351e | LoVo | 2 |
| 24900658 | 10.1021/ml300351e | A549 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| 35576702 | 10.1016/j.ejmech.2022.114424 | Serine/threonine-protein kinase PLK4 | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| 23829549 | 10.1021/jm400380m | Serine/threonine-protein kinase PLK4 | 1 |
| 24900658 | 10.1021/ml300351e | Vascular endothelial growth factor receptor 2 | 1 |
| 24900658 | 10.1021/ml300351e | Fibroblast growth factor receptor 1 | 1 |
| 24900658 | 10.1021/ml300351e | Cyclin-dependent kinase 2 | 1 |
| 24900658 | 10.1021/ml300351e | Cyclin-dependent kinase 4 | 1 |
| 24900658 | 10.1021/ml300351e | Aurora kinase A | 1 |
Data from ChEMBL 36 via Core Engine